Security key
76029N106
Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)
CUSIP: 76029N106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 82,271,724
- Total 13F shares
- 80,960,067
- Share change
- -1,016,533
- Total reported value
- $752,124,138
- Put/Call ratio
- 151%
- Price per share
- $9.29
- Number of holders
- 173
- Value change
- -$9,722,609
- Number of buys
- 82
- Number of sells
- 88
Report period
Q2 2025
Institutions
173
Top holders
10
REPL full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Replimune Group, Inc. SEC filings
Replimune Group, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76029N106
Recent filing periods:
Top shareholders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
13D/G
|
Company |
14%
from 13D/G
|
11,045,336
|
$107,692,026 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
4.8%
from 13D/G
|
3,833,033
|
$37,372,072 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
13%
|
10,853,832
|
$105,826,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.4%
|
6,061,895
|
$59,103,478 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
6%
|
4,898,527
|
$47,760,638 | — | 31 Mar 2025 | |
| FCPM III SERVICES B.V. |
13F
|
Company |
4.8%
|
3,909,696
|
$38,119,536 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.5%
|
2,900,000
|
$28,275,000 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3%
|
2,487,685
|
$24,254,930 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3%
|
2,479,939
|
$24,179,405 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
2,398,047
|
$23,380,958 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.5%
|
2,065,010
|
$20,133,848 | — | 31 Mar 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
2.4%
|
1,975,203
|
$19,258,229 | — | 31 Mar 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
2.2%
|
1,796,341
|
$17,514,325 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,672,770
|
$16,313,076 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
1.8%
|
1,461,826
|
$14,252,804 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,223,236
|
$11,926,551 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.2%
|
987,036
|
$9,623,601 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.2%
|
950,399
|
$9,266,390 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
949,872
|
$9,265,044 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
936,360
|
$9,129,510 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
928,262
|
$9,050,565 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
855,238
|
$8,338,571 | — | 31 Mar 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1%
|
850,341
|
$8,290,825 | — | 31 Mar 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
1%
|
850,000
|
$8,287,500 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.97%
|
796,580
|
$7,766,656 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.84%
|
690,167
|
$6,729,128 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.82%
|
671,411
|
$6,546,258 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
632,996
|
$6,171,712 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.69%
|
565,075
|
$5,509,481 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.69%
|
563,701
|
$5,496,085 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.67%
|
552,046
|
$5,382,449 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.56%
|
458,672
|
$4,472,049 | — | 31 Mar 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.5%
|
414,246
|
$4,038,899 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.49%
|
403,371
|
$3,932,867 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.44%
|
361,277
|
$3,522,451 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.43%
|
355,640
|
$3,467,490 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.41%
|
333,237
|
$3,249,061 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.39%
|
322,402
|
$3,143,420 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.39%
|
322,343
|
$3,142,844 | — | 31 Mar 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
0.36%
|
294,846
|
$2,874,749 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.34%
|
275,852
|
$2,689,557 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.32%
|
264,895
|
$2,582,725 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.3%
|
250,420
|
$2,441,595 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.27%
|
220,587
|
$2,150,724 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.25%
|
208,078
|
$2,028,761 | — | 31 Mar 2025 | |
| MOODY ALDRICH PARTNERS LLC |
13F
|
Company |
0.24%
|
197,385
|
$1,924,504 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
189,177
|
$1,844,477 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.22%
|
182,083
|
$1,775,309 | — | 31 Mar 2025 | |
| PDT Partners, LLC |
13F
|
Company |
0.19%
|
158,760
|
$1,547,910 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.19%
|
158,276
|
$1,543,191 | — | 31 Mar 2025 |
Institutional Holders of Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL) as of Q2 2025
As of 30 Jun 2025,
Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,960,067 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., Redmile Group, LLC, FCPM III SERVICES B.V., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, Boxer Capital Management, LLC, and RTW INVESTMENTS, LP.
This page lists
173
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
165
Q2 2025 holders
173
Holder diff
8
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.